--(BUSINESS WIRE)--DBV Technologies is the only company in the world whose products are designed to epicutaneously deliver on intact skin — via an epicutaneous patch — allergens for Epicutaneous Immunotherapy (EPIT) against food allergies or for allergy diagnosis. Using its proprietary patented delivery system VIASKIN®, DBV Technologies’ approach is to deliver biological immunoactive compounds, such as allergens, to the immune system by targeting the antigen-presenting cells present in skin. VIASKIN® is a non-invasive delivery system that utilizes electrostatic forces to present and deliver active compounds to the epidermis of the skin, without breaking the basement membrane (blood-skin barrier). As presented compounds, such as allergens, do not cross the blood-skin barrier, the risk of anaphylactic shock in allergic patients is dramatically reduced.
Help employers find you! Check out all the jobs and post your resume.
